Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Biotech Companies’ Q3 Updates: Promising Cancer Treatments on the Horizon BayStreet.ca - Thu Nov 14, 8:45AM CST

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As many biotech companies within the oncology space begin to roll...

ONCY : 1.0300 (+3.15%)
IOVA : 8.15 (+0.12%)
SNDX : 16.20 (+1.57%)
ONC.TO : 1.40 (-5.41%)
IBRX : 4.86 (-0.41%)
SWTX : 37.54 (+0.27%)
Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon Newswire.ca - Thu Nov 14, 7:00AM CST

/CNW/ -- USA News Group News Commentary – As many biotech companies within the oncology space begin to roll out their end-of-quarter results, the American...

ONCY : 1.0300 (+3.15%)
IOVA : 8.15 (+0.12%)
SNDX : 16.20 (+1.57%)
ONC.TO : 1.40 (-5.41%)
IBRX : 4.86 (-0.41%)
SWTX : 37.54 (+0.27%)
Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights Newswire.ca - Tue Nov 12, 6:00AM CST

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced third...

ONCY : 1.0300 (+3.15%)
ONC.TO : 1.40 (-5.41%)
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights Newswire.ca - Mon Nov 11, 6:00AM CST

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 1.0300 (+3.15%)
ONC.TO : 1.40 (-5.41%)
Biotech Advances Gain Momentum Amid October’s Rising Breast Cancer Rates and Awareness Efforts BayStreet.ca - Tue Oct 15, 8:31AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Each October, breast cancer awareness gains momentum through impactful campaigns and advancements in...

ONCY : 1.0300 (+3.15%)
PCSA : 0.9100 (+1.34%)
JAGX : 0.9400 (-4.07%)
BCTX : 0.6100 (+1.28%)
ONC.TO : 1.40 (-5.41%)
RHHBY : 35.1300 (-0.79%)
Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women Newswire.ca - Tue Oct 15, 6:32AM CDT

/CNW/ -- With every October, breast cancer awareness surges thanks to very effective campaigns and new developments in breast cancer treatment. However, this...

ONCY : 1.0300 (+3.15%)
HOLX : 77.79 (-0.32%)
KZIA : 5.61 (-1.75%)
ATOS : 1.2000 (-1.67%)
NVS : 103.39 (+0.29%)
ONC.TO : 1.40 (-5.41%)
KZA.AX : 0.080 (+9.59%)
FDA Oncology Approvals Accelerate as Global Cancer Rates Set to Climb 77% BayStreet.ca - Fri Oct 4, 8:19AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Although death rates for some cancers are declining, the world is facing a sharp increase in cancer...

ONCY : 1.0300 (+3.15%)
ZNTL : 3.26 (+4.25%)
TIL : 24.01 (+2.78%)
IMRX : 2.07 (+1.47%)
ZLAB : 26.30 (+0.27%)
ONC.TO : 1.40 (-5.41%)
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket FinancialNewsMedia - Fri Oct 4, 8:15AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:ABBV),(NASDAQ:BGNE),(NASDAQ:HCM),(NASDAQ:ELVN) EQNX::TICKER_END

ONCY : 1.0300 (+3.15%)
BGNE : 195.81 (+0.80%)
HCM : 17.96 (+7.22%)
ABBV : 167.92 (+0.10%)
ONC.TO : 1.40 (-5.41%)
ELVN : 25.33 (-0.39%)
FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket Newswire.ca - Fri Oct 4, 8:00AM CDT

/CNW/ -- USA News Group News Commentary – While some forms of cancer are seeing death rates fall, the world is witnessing a global surge in cancers among...

ONCY : 1.0300 (+3.15%)
BGNE : 195.81 (+0.80%)
HCM : 17.96 (+7.22%)
ABBV : 167.92 (+0.10%)
ONC.TO : 1.40 (-5.41%)
ELVN : 25.33 (-0.39%)
Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path Newswire.ca - Fri Oct 4, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, is issuing a...

ONCY : 1.0300 (+3.15%)
ONC.TO : 1.40 (-5.41%)

Barchart Exclusives

Is Palo Alto Networks Stock a Buy or Sell? Barchart - 15 minutes ago
Palo Alto delivered better-than-expected revenue and profitability in Q1, and the cybersecurity giant even raised its full-year guidance. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot